PALO ALTO, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Telik, Inc.
(Nasdaq: TELK) announced that its year-end conference call and webcast will
be held on Wednesday, February 27, 2008 at 4:30 p.m. Eastern time (1:30
p.m. Pacific time) following the release earlier that day of the company's
financial results for the fourth quarter and year ended December 31, 2007.
The conference call will be accessible via Telik's website at
http://www.telik.com or by telephone at 800-398-9398 or 612-332-0530. An
archive of the conference call will be available on the Telik website or by
telephone at 800-475-6701 or 320-365-3844, access code 910785. The archive
will be available from approximately 6:30 p.m. Eastern time on February 27
through March 12, 2008.
Telik, Inc. of Palo Alto, CA is a biopharmaceutical company focused on
discovering, developing and commercializing novel small molecule drugs to
treat serious diseases. The company's most advanced drug development
candidates are TELCYTA(R), a tumor-activated small molecule product
candidate in clinical development for the treatment of advanced ovarian
cancer and non-small cell lung cancer; and TELINTRA(R), which is in
clinical development for the treatment of myelodysplastic syndrome. Telik's
product candidates were discovered using its proprietary drug discovery
technology, TRAP(TM), which enables the rapid and efficient discovery of
small molecule drug candidates.
See Also
- North American Insurance Leaders, Inc. Postpones Stockholders Meeting
- Milady U Provides Continuing Education to Salon and Spa Professionals
- Meredith Martin Addy Named One of Top 10 Illinois 'Super Lawyers' for 2008
- Stem Cell Experts and New York Lt. Gov. David Paterson to Participate in 3rd Annual Stem Cell Summit as Keynote Speakers
Via: Healthcare
0 коментарі:
Post a Comment